Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep | 33 | 2023 | 4604 | 3.950 |
Why?
|
Workplace | 7 | 2022 | 836 | 3.000 |
Why?
|
Occupational Health | 5 | 2022 | 809 | 1.940 |
Why?
|
Sleep Initiation and Maintenance Disorders | 6 | 2023 | 997 | 1.930 |
Why?
|
Health Promotion | 10 | 2022 | 2194 | 1.890 |
Why?
|
Health Communication | 3 | 2019 | 213 | 1.460 |
Why?
|
Sleep Apnea, Obstructive | 6 | 2023 | 1808 | 1.180 |
Why?
|
Automobile Driving | 2 | 2022 | 431 | 1.140 |
Why?
|
New York City | 9 | 2022 | 706 | 0.970 |
Why?
|
Administrative Personnel | 2 | 2016 | 187 | 0.910 |
Why?
|
Dementia | 3 | 2021 | 2501 | 0.860 |
Why?
|
Loneliness | 1 | 2023 | 184 | 0.770 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2022 | 3915 | 0.650 |
Why?
|
Caregivers | 4 | 2022 | 2074 | 0.640 |
Why?
|
Narration | 1 | 2019 | 210 | 0.580 |
Why?
|
Internet | 6 | 2020 | 3062 | 0.570 |
Why?
|
Molecular Typing | 1 | 2016 | 106 | 0.560 |
Why?
|
Hypertension | 4 | 2021 | 8455 | 0.560 |
Why?
|
Students | 5 | 2023 | 1647 | 0.550 |
Why?
|
Nutritional Sciences | 1 | 2016 | 137 | 0.520 |
Why?
|
Polysomnography | 1 | 2022 | 1772 | 0.510 |
Why?
|
Awareness | 2 | 2023 | 639 | 0.500 |
Why?
|
Self Report | 3 | 2022 | 3548 | 0.490 |
Why?
|
Pandemics | 9 | 2023 | 8328 | 0.480 |
Why?
|
Persuasive Communication | 1 | 2014 | 59 | 0.470 |
Why?
|
Burnout, Professional | 2 | 2020 | 690 | 0.470 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 264 | 0.460 |
Why?
|
Parents | 3 | 2023 | 3387 | 0.430 |
Why?
|
Language | 1 | 2021 | 1458 | 0.420 |
Why?
|
Peer Group | 1 | 2017 | 635 | 0.410 |
Why?
|
Focus Groups | 3 | 2022 | 1320 | 0.400 |
Why?
|
Communication | 3 | 2023 | 3728 | 0.400 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 11039 | 0.390 |
Why?
|
Humans | 68 | 2023 | 742088 | 0.390 |
Why?
|
Public Health | 3 | 2021 | 2594 | 0.380 |
Why?
|
Health Behavior | 3 | 2022 | 2630 | 0.370 |
Why?
|
Mothers | 1 | 2021 | 2163 | 0.360 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 941 | 0.360 |
Why?
|
Attitude to Health | 2 | 2016 | 2051 | 0.350 |
Why?
|
Efficiency | 2 | 2022 | 462 | 0.320 |
Why?
|
United States | 17 | 2022 | 69693 | 0.320 |
Why?
|
Young Adult | 18 | 2023 | 56350 | 0.290 |
Why?
|
Male | 33 | 2023 | 349538 | 0.280 |
Why?
|
Program Evaluation | 3 | 2022 | 2485 | 0.280 |
Why?
|
Los Angeles | 3 | 2021 | 238 | 0.280 |
Why?
|
Accidents, Traffic | 2 | 2022 | 819 | 0.280 |
Why?
|
Video Recording | 2 | 2023 | 944 | 0.270 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1825 | 0.270 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3215 | 0.260 |
Why?
|
Female | 31 | 2023 | 379592 | 0.260 |
Why?
|
Intention | 2 | 2019 | 338 | 0.260 |
Why?
|
Consumer Health Information | 2 | 2018 | 210 | 0.260 |
Why?
|
Aged | 18 | 2023 | 162944 | 0.260 |
Why?
|
Adult | 24 | 2023 | 213712 | 0.250 |
Why?
|
Mental Recall | 2 | 2023 | 1205 | 0.240 |
Why?
|
Tuberculosis | 1 | 2016 | 1904 | 0.240 |
Why?
|
Adolescent | 15 | 2022 | 85649 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2853 | 0.220 |
Why?
|
Genotype | 1 | 2016 | 12946 | 0.210 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 24913 | 0.210 |
Why?
|
Time | 1 | 2023 | 530 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5304 | 0.200 |
Why?
|
Alzheimer Disease | 1 | 2022 | 7988 | 0.190 |
Why?
|
Health Policy | 1 | 2013 | 2657 | 0.190 |
Why?
|
Anxiety | 4 | 2023 | 4279 | 0.190 |
Why?
|
Sleep Deprivation | 3 | 2023 | 830 | 0.190 |
Why?
|
London | 1 | 2021 | 233 | 0.190 |
Why?
|
Technology | 1 | 2023 | 303 | 0.190 |
Why?
|
Depression | 5 | 2023 | 7733 | 0.190 |
Why?
|
Residence Characteristics | 2 | 2021 | 2049 | 0.180 |
Why?
|
Absenteeism | 1 | 2022 | 250 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1683 | 0.170 |
Why?
|
Achievement | 1 | 2021 | 291 | 0.170 |
Why?
|
Middle Aged | 16 | 2022 | 213127 | 0.170 |
Why?
|
Medicare | 3 | 2022 | 6532 | 0.170 |
Why?
|
Health Literacy | 2 | 2022 | 414 | 0.170 |
Why?
|
Positive-Pressure Respiration | 1 | 2023 | 632 | 0.170 |
Why?
|
Quarantine | 1 | 2021 | 167 | 0.170 |
Why?
|
Nurse Practitioners | 1 | 2022 | 270 | 0.160 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2023 | 546 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3130 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3236 | 0.160 |
Why?
|
Sweden | 1 | 2021 | 1343 | 0.150 |
Why?
|
Communicable Disease Control | 2 | 2021 | 854 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1631 | 0.150 |
Why?
|
Demography | 1 | 2022 | 1650 | 0.150 |
Why?
|
Mother-Child Relations | 1 | 2021 | 481 | 0.150 |
Why?
|
Public Opinion | 1 | 2021 | 477 | 0.150 |
Why?
|
Risk-Taking | 1 | 2021 | 986 | 0.140 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13921 | 0.130 |
Why?
|
China | 1 | 2021 | 2246 | 0.130 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2016 | 768 | 0.130 |
Why?
|
Employment | 1 | 2022 | 1124 | 0.130 |
Why?
|
Regression Analysis | 2 | 2016 | 6452 | 0.130 |
Why?
|
Suicidal Ideation | 2 | 2021 | 1246 | 0.120 |
Why?
|
Molecular Epidemiology | 1 | 2016 | 468 | 0.120 |
Why?
|
Emotions | 2 | 2023 | 2657 | 0.120 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4250 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1515 | 0.120 |
Why?
|
Health Education | 2 | 2020 | 1053 | 0.120 |
Why?
|
Universities | 2 | 2023 | 953 | 0.120 |
Why?
|
Learning | 1 | 2023 | 1705 | 0.120 |
Why?
|
Prospective Studies | 4 | 2023 | 53187 | 0.110 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 365 | 0.110 |
Why?
|
Organizational Policy | 1 | 2016 | 427 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1526 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 704 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2016 | 748 | 0.110 |
Why?
|
Internship and Residency | 2 | 2023 | 5774 | 0.100 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2013 | 303 | 0.100 |
Why?
|
DNA, Bacterial | 1 | 2016 | 1465 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 2020 | 5249 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1768 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40054 | 0.100 |
Why?
|
Cities | 1 | 2013 | 511 | 0.100 |
Why?
|
Risk Factors | 5 | 2023 | 72145 | 0.100 |
Why?
|
Comprehension | 1 | 2016 | 608 | 0.100 |
Why?
|
New York | 1 | 2013 | 886 | 0.100 |
Why?
|
Mental Disorders | 2 | 2021 | 6587 | 0.100 |
Why?
|
Interviews as Topic | 1 | 2018 | 2536 | 0.090 |
Why?
|
Prevalence | 4 | 2023 | 15194 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2018 | 2451 | 0.090 |
Why?
|
Schools | 1 | 2019 | 1425 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 384 | 0.090 |
Why?
|
Mass Media | 1 | 2013 | 303 | 0.090 |
Why?
|
Information Dissemination | 1 | 2018 | 1100 | 0.090 |
Why?
|
Aniline Compounds | 1 | 2015 | 983 | 0.090 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2275 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57683 | 0.090 |
Why?
|
Culture | 1 | 2014 | 632 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1038 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2013 | 488 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2623 | 0.090 |
Why?
|
Life Style | 1 | 2021 | 3824 | 0.090 |
Why?
|
Qualitative Research | 1 | 2018 | 2680 | 0.080 |
Why?
|
Pilot Projects | 1 | 2022 | 8297 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 3014 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1794 | 0.080 |
Why?
|
Australia | 2 | 2021 | 1167 | 0.080 |
Why?
|
Disease Management | 1 | 2018 | 2450 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2706 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.070 |
Why?
|
Pain | 1 | 2022 | 4961 | 0.070 |
Why?
|
Software | 1 | 2021 | 4434 | 0.070 |
Why?
|
Primary Health Care | 2 | 2022 | 4551 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.070 |
Why?
|
Child | 6 | 2023 | 77478 | 0.070 |
Why?
|
Sulfonamides | 1 | 2015 | 1932 | 0.070 |
Why?
|
Blood Pressure | 1 | 2021 | 8541 | 0.060 |
Why?
|
Quality of Life | 2 | 2022 | 12730 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7901 | 0.060 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13019 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5611 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4554 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8626 | 0.050 |
Why?
|
Psychometrics | 2 | 2022 | 2999 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 2986 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5522 | 0.050 |
Why?
|
Organizations | 1 | 2022 | 170 | 0.050 |
Why?
|
Knowledge | 1 | 2022 | 179 | 0.050 |
Why?
|
Endocrine Cells | 1 | 2020 | 10 | 0.050 |
Why?
|
Exocrine Glands | 1 | 2020 | 50 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2022 | 975 | 0.040 |
Why?
|
Child, Preschool | 2 | 2022 | 40955 | 0.040 |
Why?
|
Geography | 1 | 2020 | 669 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2022 | 747 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10163 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12705 | 0.040 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 112 | 0.040 |
Why?
|
Social Isolation | 1 | 2020 | 363 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16665 | 0.040 |
Why?
|
Mental Health | 2 | 2021 | 2997 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2016 | 25575 | 0.040 |
Why?
|
Sex Factors | 2 | 2020 | 10392 | 0.030 |
Why?
|
Cognition | 1 | 2014 | 6722 | 0.030 |
Why?
|
Workload | 1 | 2022 | 849 | 0.030 |
Why?
|
Neoplasms | 2 | 2015 | 21596 | 0.030 |
Why?
|
Child Behavior | 1 | 2021 | 838 | 0.030 |
Why?
|
Commerce | 1 | 2020 | 591 | 0.030 |
Why?
|
Infant | 1 | 2016 | 35070 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15108 | 0.030 |
Why?
|
Schools, Medical | 1 | 2021 | 878 | 0.030 |
Why?
|
Prostate | 1 | 2022 | 1764 | 0.030 |
Why?
|
Trust | 1 | 2018 | 501 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11472 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
Hospitalization | 2 | 2023 | 10232 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1092 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 608 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9735 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1875 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1215 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2015 | 853 | 0.030 |
Why?
|
Attention | 1 | 2023 | 2396 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2022 | 5062 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2715 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8425 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 77098 | 0.030 |
Why?
|
Morpholines | 1 | 2015 | 561 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13256 | 0.030 |
Why?
|
Social Support | 1 | 2021 | 2117 | 0.020 |
Why?
|
Social Class | 1 | 2020 | 1995 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4030 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2575 | 0.020 |
Why?
|
Mice | 4 | 2020 | 81045 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10472 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2940 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1158 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1969 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2384 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 952 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1119 | 0.020 |
Why?
|
Animals | 6 | 2020 | 168561 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6313 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6347 | 0.020 |
Why?
|
Uncertainty | 1 | 2013 | 725 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3564 | 0.020 |
Why?
|
Coenzyme A-Transferases | 1 | 1987 | 7 | 0.020 |
Why?
|
Clinical Competence | 1 | 2023 | 4681 | 0.020 |
Why?
|
Ketone Bodies | 1 | 1987 | 81 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3611 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23387 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15994 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2107 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5975 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5519 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2015 | 2723 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19862 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Oligodendroglia | 1 | 1987 | 514 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5163 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4553 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21821 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11363 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9410 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2015 | 19223 | 0.010 |
Why?
|
Neuroglia | 1 | 1987 | 925 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5979 | 0.010 |
Why?
|
Astrocytes | 1 | 1987 | 1266 | 0.010 |
Why?
|
Fatty Acids | 1 | 1987 | 1806 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9715 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7873 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29717 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1987 | 2896 | 0.010 |
Why?
|
Glucose | 1 | 1987 | 4391 | 0.010 |
Why?
|
Sulfurtransferases | 1 | 1987 | 17 | 0.000 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 1987 | 56 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1987 | 2191 | 0.000 |
Why?
|
Substrate Specificity | 1 | 1987 | 1802 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1987 | 2723 | 0.000 |
Why?
|
Brain | 1 | 1987 | 26343 | 0.000 |
Why?
|
Rats | 1 | 1987 | 24265 | 0.000 |
Why?
|
Concepts
(257)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_